Not all stage I and II endometrial cancers are created equal: Recurrence-free survival and cause-specific survival after observation or vaginal brachytherapy alone in all subgroups of early-stage high-intermediate and high-risk endometrial cancer.
Gynecol Oncol
; 167(3): 444-451, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36244826
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Braquiterapia
/
Neoplasias do Endométrio
/
Carcinoma Endometrioide
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article